Press Release

< Back to Press Releases

Jnana Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

Boston, Mass., January 6, 2022 Jnana Therapeutics, a biotechnology company utilizing its next generation chemoproteomic platform to pursue well-validated but hard-to-drug targets, today announced that Joanne Kotz, Ph.D., Co-founder and Chief Executive Officer, will present a corporate overview at the 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022 at 10:30 a.m. ET. 

About Jnana Therapeutics
Jnana Therapeutics is a biotechnology company utilizing its RAPID platform to address well-validated but hard-to-drug targets, including the solute carrier (SLC) family of metabolite transporters. Jnana is focused on developing best-in-class therapies to treat a wide range of diseases, including rare and immune-mediated diseases and cancer. Headquartered in Boston, Jnana is founded by world-renowned scientists and backed by leading life science investors. For more information, please visit www.jnanatx.com and follow us on Twitter and on LinkedIn.

Media Contact:
Kathryn Morris
The Yates Network
914-204-6412
[email protected]

Back to Top
 

This links to an external website. Merus is not responsible for any third party content.

Continue